While estrogen therapy has numerous benefits, it also carries potential risks. Prolonged unopposed estrogen exposure can lead to endometrial hyperplasia and, in some cases, carcinoma. Additionally, the proliferative effects on breast tissue may increase the risk of breast cancer. Histological monitoring is essential to detect these adverse changes early.
